Daniel Landi

2.7k total citations
52 papers, 292 citations indexed

About

Daniel Landi is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Daniel Landi has authored 52 papers receiving a total of 292 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Genetics, 14 papers in Molecular Biology and 13 papers in Oncology. Recurrent topics in Daniel Landi's work include Glioma Diagnosis and Treatment (24 papers), Neuroblastoma Research and Treatments (10 papers) and Immunotherapy and Immune Responses (6 papers). Daniel Landi is often cited by papers focused on Glioma Diagnosis and Treatment (24 papers), Neuroblastoma Research and Treatments (10 papers) and Immunotherapy and Immune Responses (6 papers). Daniel Landi collaborates with scholars based in United States, Canada and Australia. Daniel Landi's co-authors include David M. Ashley, Eric M. Thompson, Nirmish Shah, Annick Desjardins, Meenakshi Hegde, Radhika Shah, Nabil Ahmed, Laura M. De Castro, Darell D. Bigner and Henry S. Friedman and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Daniel Landi

45 papers receiving 287 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Landi United States 10 165 81 64 53 47 52 292
Xinmiao Jiang China 11 54 0.3× 47 0.6× 92 1.4× 54 1.0× 41 0.9× 31 346
Christopher Wragg United Kingdom 10 162 1.0× 124 1.5× 34 0.5× 45 0.8× 19 0.4× 17 361
Nazaneen N. Grant United States 10 71 0.4× 61 0.8× 78 1.2× 24 0.5× 29 0.6× 18 371
Manjari Pandey United States 12 85 0.5× 59 0.7× 166 2.6× 39 0.7× 68 1.4× 20 332
Lucrezia della Volpe Italy 5 113 0.7× 266 3.3× 61 1.0× 28 0.5× 43 0.9× 10 468
Claudia Sampor Argentina 14 130 0.8× 99 1.2× 131 2.0× 93 1.8× 60 1.3× 31 491
Ingrid Kühnle Germany 8 165 1.0× 51 0.6× 24 0.4× 104 2.0× 29 0.6× 15 281
Francesco Autore Italy 11 169 1.0× 49 0.6× 79 1.2× 14 0.3× 87 1.9× 54 316
Tung Wynn United States 11 88 0.5× 60 0.7× 31 0.5× 39 0.7× 17 0.4× 23 306
Yohann Schmitt France 8 178 1.1× 91 1.1× 28 0.4× 48 0.9× 16 0.3× 12 339

Countries citing papers authored by Daniel Landi

Since Specialization
Citations

This map shows the geographic impact of Daniel Landi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Landi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Landi more than expected).

Fields of papers citing papers by Daniel Landi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Landi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Landi. The network helps show where Daniel Landi may publish in the future.

Co-authorship network of co-authors of Daniel Landi

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Landi. A scholar is included among the top collaborators of Daniel Landi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Landi. Daniel Landi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fulton, Ailsa, Joseph G. Rogers, Beiyu Liu, et al.. (2025). Comparison of single- versus multi-drug treatment for intra-arterial chemotherapy (IAC) in children with retinoblastoma. Interventional Neuroradiology. 4004400252–4004400252.
2.
Fangusaro, Jason, Arzu Onar‐Thomas, Tina Young Poussaint, et al.. (2025). A phase 2 PBTC study of selumetinib for recurrent/progressive pediatric low-grade glioma: Strata 2, 5, and 6 with long-term outcomes on strata 1, 3, and 4. Neuro-Oncology. 27(9). 2415–2428. 2 indexed citations
3.
Thompson, Eric M., David M. Ashley, Pamela K. Norberg, et al.. (2024). Outcomes and immune response after peptide vaccination targeting human cytomegalovirus antigen pp65 in children and young adults with recurrent high-grade glioma and medulloblastoma.. Journal of Clinical Oncology. 42(16_suppl). 2039–2039. 4 indexed citations
4.
Price, Mackenzie, Katherine Ryan, Corey Neff, et al.. (2023). Childhood, adolescent, and adult primary brain and central nervous system tumor statistics for practicing healthcare providers in neuro-oncology, CBTRUS 2015–2019. Neuro-Oncology Practice. 11(1). 5–25. 17 indexed citations
5.
Brown, Michael C., Georgia M. Beasley, Yuanfan Yang, et al.. (2023). Intratumor childhood vaccine-specific CD4+ T-cell recall coordinates antitumor CD8+ T cells and eosinophils. Journal for ImmunoTherapy of Cancer. 11(4). e006463–e006463. 4 indexed citations
6.
Cohen, Kenneth J., Dolly Aguilera, Robert C. Castellino, et al.. (2023). A Pilot Study Omitting Radiation in the Treatment of Children with Newly Diagnosed Wnt-Activated Medulloblastoma. Clinical Cancer Research. 29(24). 5031–5037. 9 indexed citations
7.
Peters, Katherine B., Daniel Landi, Gloria Broadwater, et al.. (2023). Use, access, and initial outcomes of off-label ivosidenib in patients with IDH1 mutant glioma. Neuro-Oncology Practice. 11(2). 199–204. 11 indexed citations
8.
Russ, Jeffrey B., et al.. (2023). Maternal Prenatal Use of Alcohol, Tobacco, and Illicit Drugs and Associations with Childhood Cancer Subtypes. Cancer Epidemiology Biomarkers & Prevention. 33(3). 347–354. 3 indexed citations
9.
Thompson, Eric M., Daniel Landi, Michael C. Brown, et al.. (2023). Recombinant polio–rhinovirus immunotherapy for recurrent paediatric high-grade glioma: a phase 1b trial. The Lancet Child & Adolescent Health. 7(7). 471–478. 29 indexed citations
10.
Cioffi, Gino, Kristin Waite, Jonathan L. Finlay, et al.. (2022). Incidence and survival of choroid plexus tumors in the United States. Neuro-Oncology Practice. 10(1). 41–49. 5 indexed citations
11.
Cioffi, Gino, Kristin Waite, Quinn T. Ostrom, et al.. (2022). Epidemiology of pineoblastoma in the United States, 2000–2017. Neuro-Oncology Practice. 9(2). 149–157. 9 indexed citations
12.
Landi, Daniel, et al.. (2022). EPID-22. MATERNAL USE OF TOBACCO, ALCOHOL, AND ILLICIT DRUGS DURING PREGNANCY AND ASSOCIATION WITH CHILDHOOD CANCER SUBTYPES. Neuro-Oncology. 24(Supplement_7). vii114–vii114. 1 indexed citations
13.
Thompson, Eric M., David M. Ashley, & Daniel Landi. (2020). Current medulloblastoma subgroup specific clinical trials. Translational Pediatrics. 9(2). 157–162. 38 indexed citations
14.
Thompson, Eric M., Daniel Landi, David M. Ashley, Stephen T. Keir, & Darell D. Bigner. (2018). Bevacizumab, irinotecan, temozolomide, tyrosine kinase inhibition, and MEK inhibition are effective against pleomorphic xanthoastrocytoma regardless of V600E status. Journal of Neuro-Oncology. 140(2). 261–268. 10 indexed citations
15.
Wakefield, Amanda, Antonella Pignata, Alexia Ghazi, et al.. (2015). Is CMV a target in pediatric glioblastoma? Expression of CMV proteins, pp65 and IE1-72 and CMV nucleic acids in a cohort of pediatric glioblastoma patients. Journal of Neuro-Oncology. 125(2). 307–315. 24 indexed citations
16.
Landi, Daniel, Meenakshi Hegde, & Nabil Ahmed. (2014). Human Cytomegalovirus Antigens in Malignant Gliomas as Targets for Adoptive Cellular Therapy. Frontiers in Oncology. 4. 338–338. 8 indexed citations
17.
18.
Landi, Daniel, Michele G. Beckman, Nirmish Shah, et al.. (2013). Characteristics of abdominal vein thrombosis in children and adults. Thrombosis and Haemostasis. 109(4). 625–632. 5 indexed citations
19.
Shah, Nirmish, Daniel Landi, Radhika Shah, et al.. (2011). Complications of implantable venous access devices in patients with sickle cell disease. American Journal of Hematology. 87(2). 224–226. 25 indexed citations
20.
Shah, Nirmish, et al.. (2011). Presentation and Outcomes for Children With Bone Marrow Necrosis and Acute Lymphoblastic Leukemia. Journal of Pediatric Hematology/Oncology. 33(7). e316–e319. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xinmiao Jiang Breakdown of academic impact, for papers by Christopher Wragg Breakdown of academic impact, for papers by Nazaneen N. Grant Breakdown of academic impact, for papers by Manjari Pandey Breakdown of academic impact, for papers by Lucrezia della Volpe Breakdown of academic impact, for papers by Claudia Sampor Breakdown of academic impact, for papers by Ingrid Kühnle Breakdown of academic impact, for papers by Francesco Autore Breakdown of academic impact, for papers by Tung Wynn Breakdown of academic impact, for papers by Yohann Schmitt
Rankless by CCL
2026